All In MedTech

FDA Clearance Tracker · P950014-S020

PROSTATRON

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 13, 2000 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P950014-S020
Device name
PROSTATRON
Applicant location
Plymouth, MN
Received
Nov 26, 1999
Decided
Apr 13, 2000
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P950014

Device type

Device class
Class III

Every decision under product code MEQ

FDA's approval statement

As written in FDA's record.

Approval for changes to the Prostatron software program to include the 30-Minute TUMT treatment protocol.

Source documents

Other decisions for Urologix, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.